Hypertriglyceridemia

The Hypertriglyceridemia Study is focused on understanding and managing high triglyceride levels in the bloodstream — a key risk factor for heart disease, pancreatitis, and metabolic disorders. This research evaluates how lifestyle, genetics, and medication affect triglyceride production and breakdown to develop safer, more effective treatment options.

1. Lipid Profile and Blood Analysis

• Measures triglycerides, cholesterol, and other lipid markers to assess cardiovascular risk.

• Identifies imbalances in lipid metabolism and monitors progress throughout treatment.
  
  

2. Dietary and Lifestyle Evaluation

• Examines participants’ nutrition, exercise habits, and overall metabolic health.

• Helps determine how lifestyle interventions can lower triglyceride levels naturally.
  
  

3. Genetic and Hormonal Testing

• Evaluates hereditary factors or hormonal imbalances that contribute to elevated triglycerides.

• Provides insight into individualized treatment approaches.
  
  

4. Investigational Drug Trials

• Tests new or combination therapies that aim to lower triglyceride levels more effectively and safely.

• Continuous monitoring ensures treatment efficiency and participant safety.
  
  

Eligible Participants Are

• 18 to 75 years of age

• Diagnosed with hypertriglyceridemia (elevated triglyceride levels)

• Fasting triglyceride levels typically above 150 mg/dL (criteria may vary by study)

• May have additional risk factors such as diabetes, obesity, or family history of lipid disorders

• Willing to undergo regular blood tests and lifestyle assessments

• Additional criteria apply
  
  

Eligible Participants May

• Receive study-related medical care and treatment at no cost

• Receive compensation for study-related time and travel

• Gain access to investigational lipid-lowering therapies

• Contribute to advancing cardiovascular and metabolic health research
  
  

The Hypertriglyceridemia Clinical Trial plays a vital role in advancing medical knowledge of lipid disorders and creating new strategies to prevent heart disease and metabolic complications. Participants contribute to developing therapies that promote long-term cardiovascular health.